EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 23 / No 10 (Octobre 2007) Med Sci (Paris), 23 10 (2007) 845-849 References
Free Access
Issue
Med Sci (Paris)
Volume 23, Number 10, Octobre 2007
Page(s) 845 - 849
Section M/S revues
DOI https://doi.org/10.1051/medsci/20072310845
Published online 15 October 2007
  1. The Huntington’s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 1993; 72 : 971–83. [Google Scholar]
  2. Liévens JC, Birman S. La chorée de Huntington chez la drosophile et chez la souris: vers de nouvelles pistes thérapeutiques ? Med Sci (Paris) 2003; 19 : 593–9. [Google Scholar]
  3. Chneiweiss H. Les astrocytes contrôlent la neurogenèse dans le système nerveux central. Med Sci (Paris) 2002; 18 : 1065–6. [Google Scholar]
  4. Volterra A, Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 2005; 6 : 626–40. [Google Scholar]
  5. Danbolt NC. Glutamate uptake. Prog Neurobiol 2001; 65 : 1–105. [Google Scholar]
  6. Matute C, Domercq M, Sanchez-Gomez MV. Glutamate-mediated glial injury: mechanisms and clinical importance. Glia 2006; 53 : 212–24. [Google Scholar]
  7. Hansson E, Ronnback L. Glial neuronal signaling in the central nervous system. FASEB J 2003; 17 : 341–8. [Google Scholar]
  8. Singhrao SK, Thomas P, Wood JD, et al. Huntingtin protein colocalizes with lesions of neurodegenerative diseases: An investigation in Huntington’s, Alzheimer’s, and Pick’s diseases. Exp Neurol 1998; 150 : 213–22. [Google Scholar]
  9. Hebb MO, Denovan-Wright EM, Robertson HA. Expression of the Huntington’s disease gene is regulated in astrocytes in the arcuate nucleus of the hypothalamus of postpartum rats. FASEB J 1999; 13 : 1099–106. [Google Scholar]
  10. Shin JY, Fang ZH, Yu ZX, et al. Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity. J Cell Biol 2005; 171 : 1001–12. [Google Scholar]
  11. Cross AJ, Slater P, Reynolds GP. Reduced high-affinity glutamate uptake sites in the brains of patients with Huntington’s disease. Neurosci Lett 1986; 67 : 198–202. [Google Scholar]
  12. Arzberger T, Krampfl K, Leimgruber S, Weindl A. Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington’s disease-an in situ hybridization study. J Neuropathol Exp Neurol 1997; 56 : 440–54. [Google Scholar]
  13. Hermel E, Gafni J, Propp SS, et al. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington’s disease. Cell Death Differ 2004; 11 : 424–38. [Google Scholar]
  14. Vis JC, Schipper E, de Boer-van Huizen RT, et al. Expression pattern of apoptosis-related markers in Huntington’s disease. Acta Neuropathol (Berl) 2005; 109 : 321–8. [Google Scholar]
  15. Lievens JC, Woodman B, Mahal A, et al. Impaired glutamate uptake in the R6 Huntington’s disease transgenic mice. Neurobiol Dis 2001; 8 : 807–21. [Google Scholar]
  16. Behrens PF, Franz P, Woodman B, et al. Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation. Brain 2002; 125 : 1908–22. [Google Scholar]
  17. Nicniocaill B, Haraldsson B, Hansson O, et al. Altered striatal amino acid neurotransmitter release monitored using microdialysis in R6/1 Huntington transgenic mice. Eur J Neurosci 2001; 13 : 206–10. [Google Scholar]
  18. Rival T, Soustelle L, Strambi C, et al. Decreasing glutamate buffering capacity triggers oxidative stress and neuropil degeneration in the Drosophila brain. Curr Biol 2004; 14 : 599–605. [Google Scholar]
  19. Liévens JC, Rival T, Iche M, Chneiweiss H, Birman S. Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila. Hum Mol Genet 2005; 14 : 713–24. [Google Scholar]
  20. Kretzschmar D, Tschape J, Bettencourt Da Cruz A, et al. Glial and neuronal expression of polyglutamine proteins induce behavioral changes and aggregate formation in Drosophila. Glia 2005; 49 : 59–72. [Google Scholar]
  21. Custer SK, Garden GA, Gill N, et al. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat Neurosci 2006; 9 : 1302–11. [Google Scholar]
  22. Junier MP. What role(s) for TGFalpha in the central nervous system ? Prog Neurobiol 2000; 62 : 443–73. [Google Scholar]
  23. Figiel M, Maucher T, Rozyczka J, et al. Regulation of glial glutamate transporter expression by growth factors. Exp Neurol 2003; 183 : 124–35. [Google Scholar]
  24. Song C, Perides G, Liu YF. Expression of full-length polyglutamine-expanded Huntingtin disrupts growth factor receptor signaling in rat pheochromocytoma (PC12) cells. J Biol Chem 2002; 277 : 6703–7. [Google Scholar]
  25. Li SH, Yu ZX, Li CL, et al. Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington’s disease. J Neurosci 2003; 23 : 6956–64. [Google Scholar]
  26. Bradley SV, Holland EC, Liu GY, et al. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor. Cancer Res 2007; 67 : 3609–15. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.